MiR-371a-3p in cystic trophoblastic tumour of the testis: supporting a maturation phenomenon towards teratoma

被引:2
|
作者
Lobo, Joao [1 ,2 ,3 ,4 ]
Tavares, Nuno Tiago [2 ,3 ]
Barros-Silva, Daniela [2 ,3 ]
Rosinha, Alina [5 ]
Morais, Antonio [6 ]
Jeronimo, Carmen [2 ,3 ,4 ]
Rodrigues, Angelo [1 ,2 ,3 ,4 ]
Henrique, Rui [1 ,2 ,3 ,4 ]
机构
[1] Portuguese Oncol Inst Porto IPOP, Dept Pathol, Porto, Portugal
[2] Portuguese Oncol Inst Porto IPO Porto, IPO Porto Res Ctr GEBC CI IPOP, Canc Biol & Epigenet Grp, Porto, Portugal
[3] Prto Comprehens Canc Ctr P CCC, Porto, Portugal
[4] Univ Porto ICBAS UP, Inst Biomed Sci Abel Salazar, Dept Pathol & Mol Immunol, Porto, Portugal
[5] Portuguese Oncol Inst Porto IPOP, Dept Med Oncol, Porto, Portugal
[6] Portuguese Oncol Inst Porto IPOP, Dept Urol, Porto, Portugal
关键词
D O I
10.1111/his.14929
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:151 / 154
页数:4
相关论文
共 50 条
  • [21] MicroRNA miR-371a-3p in serum: A sensitive and specific new biomarker for (testicular) germ cell tumors
    Zengerling F.
    Der Onkologe, 2017, 23 (5): : 389 - 390
  • [22] Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors
    Murray, Matthew J.
    Ajithkumar, Thankamma
    Harris, Fiona
    Williams, Rachel M.
    Jalloh, Ibrahim
    Cross, Justin
    Ronghe, Milind
    Ward, Dawn
    Scarpini, Cinzia G.
    Nicholson, James C.
    Coleman, Nicholas
    NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [23] Digimir test: a novel pipeline for mir-371a-3p quantification using droplet digital PCR in liquid biopsies of testicular germ cell tumour patients
    Lobo, J.
    Sequeira, J. P.
    Constancio, V.
    Brito-Rocha, T.
    Carvalho-Maia, C.
    Braga, I.
    Mauricio, J.
    Henrique, R.
    Jeronimo, C.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S140 - S140
  • [24] Testicular Germ Cell Tumors Go Epigenetics: Will miR-371a-3p Replace Classical Serum Biomarkers?
    Henrique, Rui
    Jeronimo, Carmen
    EUROPEAN UROLOGY, 2017, 71 (02) : 221 - 222
  • [25] MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker
    Spiekermann, M.
    Belge, G.
    Winter, N.
    Ikogho, R.
    Balks, T.
    Bullerdiek, J.
    Dieckmann, K. -P.
    ANDROLOGY, 2015, 3 (01) : 78 - 84
  • [26] miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy
    Plaza, Ximena Rosas
    van Agthoven, Ton
    Meijer, Coby
    van Vugt, Marcel A. T. M.
    de Jong, Steven
    Gietema, Jourik A.
    Looijenga, Leendert H. J.
    CELLS, 2019, 8 (10)
  • [27] Validation of plasma miR-371a-3p expression in patients with metastatic and early stage germ cell tumor.
    Nappi, Lucia
    Thi, Marisa
    Lum, Amy
    Huntsman, David
    Eigl, Bernhard J.
    Chi, Kim N.
    Martin, Christopher
    Neil, Brock O.
    Maughan, Benjamin Louis
    So, Alan
    Black, Peter C.
    Gleave, Martin
    Wyatt, Alexander William
    Lavoie, Jean-Michel
    Khalaf, Daniel
    Daneshmand, Siamak
    Hamilton, Robert James
    Leao, Ricardo Romao Nazario
    Nichols, Craig R.
    Kollmannsberger, Christian K.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [28] The Diagnostic Accuracy of miR-371a-3p for Testicular Germ Cell Tumors: A Systematic Review and Meta-Analysis
    Qiangzhao Liu
    Qiong Lian
    Haidi Lv
    Xiaofeng Zhang
    Fenghai Zhou
    Molecular Diagnosis & Therapy, 2021, 25 : 273 - 281
  • [29] Advancing GCT Management: A Review of miR-371a-3p and Other miRNAs in Comparison to Traditional Serum Tumor Markers
    Seales, Crystal L.
    Puri, Dhruv
    Yodkhunnatham, Nuphat
    Pandit, Kshitij
    Yuen, Kit
    Murray, Sarah
    Smitham, Jane
    Lafin, John T.
    Bagrodia, Aditya
    CANCERS, 2024, 16 (07)
  • [30] Is measuring serum levels of microRNA miR-371a-3p superior to the classical biomarkers of testicular germ cell tumors?
    Dieckmann, Klaus-Peter
    Spiekerrnann, Meike
    Ruf, Christian G.
    Oechsle, Karin
    Bullerdiek, Joern
    Beige, Gazanfer
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)